|
1.Type of personnel changed (please enter: spokesperson, acting
spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
, financial officer, accounting officer, corporate governance officer,
chief information security officer, research and development officer,
chief internal auditor, or designated and non-designated representatives):
financial officer, accounting officer, corporate governance officer
and acting spokesperson
2.Date of occurrence of the change: 2026/09/11
3.Name, title, and resume of the previous position holder:
Kuan-Chieh Wang/Finance Manager, Chunghwa Chemical
Synthesis & Biotech Co., Ltd./
financial officer, accounting officer, corporate governance officer
and acting spokesperson
4.Name, title, and resume of the new position holder:
NA
5.Type of the change (please enter: "resignation", "position
adjustment", "retirement", "death","new
replacement" or "dismissal"): resignation
6.Reason for the change: Personal career planning
7.Effective date: 2026/09/12
8.Any other matters that need to be specified:
The appointments of the financial officer, accounting officer,
corporate governance officer and acting spokesperson will be
announced after board approval.
|
